Thermo Fisher Scientific Specialty Diagnostics — Other segment items increased by 14.8% to -$46.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.8%, from -$54.00M to -$46.00M.
Large values warrant investigation as they often represent non-operational, one-time events that distort underlying segment performance.
Miscellaneous income or expense items specific to the Specialty Diagnostics segment that do not fall into standard categ...
Varies widely by company accounting practices and reporting transparency.
tmo_segment_specialty_diagnostics_other_segment_items| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | -$43.50M | -$43.50M | -$43.50M | -$43.50M | -$54.00M | -$46.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -24.1% | +14.8% |
| YoY Change | — | — | — | — | -24.1% | +14.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.